PMC:7405836 / 116210-116564 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T40","span":{"begin":237,"end":251},"obj":"Body_part"},{"id":"T41","span":{"begin":237,"end":241},"obj":"Body_part"},{"id":"T42","span":{"begin":345,"end":353},"obj":"Body_part"}],"attributes":[{"id":"A40","pred":"fma_id","subj":"T40","obj":"http://purl.org/sig/ont/fma/fma63841"},{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A42","pred":"fma_id","subj":"T42","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"The exploration of fully human antibodies (human single-chain antibodies; HuscFvs) or humanized nanobodies (single-domain antibodies; sdAb, VH/VHH) could aid in blocking virus replication, as these agents can traverse the virus-infected cell membranes (transbodies) and can interfere with the biological characteristics of the replicating virus proteins."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T117","span":{"begin":25,"end":30},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T118","span":{"begin":43,"end":48},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T119","span":{"begin":86,"end":95},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T120","span":{"begin":170,"end":175},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T121","span":{"begin":222,"end":227},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T122","span":{"begin":237,"end":241},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T123","span":{"begin":242,"end":251},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T124","span":{"begin":339,"end":344},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"The exploration of fully human antibodies (human single-chain antibodies; HuscFvs) or humanized nanobodies (single-domain antibodies; sdAb, VH/VHH) could aid in blocking virus replication, as these agents can traverse the virus-infected cell membranes (transbodies) and can interfere with the biological characteristics of the replicating virus proteins."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T234","span":{"begin":140,"end":142},"obj":"Chemical"},{"id":"T235","span":{"begin":345,"end":353},"obj":"Chemical"}],"attributes":[{"id":"A234","pred":"chebi_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/CHEBI_73700"},{"id":"A235","pred":"chebi_id","subj":"T235","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"The exploration of fully human antibodies (human single-chain antibodies; HuscFvs) or humanized nanobodies (single-domain antibodies; sdAb, VH/VHH) could aid in blocking virus replication, as these agents can traverse the virus-infected cell membranes (transbodies) and can interfere with the biological characteristics of the replicating virus proteins."}

{"project":"LitCovid-sentences","denotations":[{"id":"T788","span":{"begin":0,"end":354},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The exploration of fully human antibodies (human single-chain antibodies; HuscFvs) or humanized nanobodies (single-domain antibodies; sdAb, VH/VHH) could aid in blocking virus replication, as these agents can traverse the virus-infected cell membranes (transbodies) and can interfere with the biological characteristics of the replicating virus proteins."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3174","span":{"begin":154,"end":157},"obj":"Gene"},{"id":"3182","span":{"begin":25,"end":30},"obj":"Species"},{"id":"3183","span":{"begin":43,"end":48},"obj":"Species"},{"id":"3184","span":{"begin":222,"end":236},"obj":"Disease"}],"attributes":[{"id":"A3174","pred":"tao:has_database_id","subj":"3174","obj":"Gene:57379"},{"id":"A3182","pred":"tao:has_database_id","subj":"3182","obj":"Tax:9606"},{"id":"A3183","pred":"tao:has_database_id","subj":"3183","obj":"Tax:9606"},{"id":"A3184","pred":"tao:has_database_id","subj":"3184","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The exploration of fully human antibodies (human single-chain antibodies; HuscFvs) or humanized nanobodies (single-domain antibodies; sdAb, VH/VHH) could aid in blocking virus replication, as these agents can traverse the virus-infected cell membranes (transbodies) and can interfere with the biological characteristics of the replicating virus proteins."}